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Ticks are notorious vectors of disease for humans, and many species of ticks transmit multiple pathogens, sometimes
in the same tick bite. Accordingly, a broad-spectrum vaccine that targets vector ticks and pathogen transmission at the
tick/host interface, rather than multiple vaccines against every possible tickborne pathogen, could become an
important tool for resolving an emerging public health crisis. The concept for such a tick protective vaccine comes from
observations of an acquired tick resistance (ATR) that can develop in non-natural hosts of ticks following sensitization to
tick salivary components. Mice are commonly used as models to study immune responses to human pathogens but
normal mice are natural hosts for many species of ticks and fail to develop ATR. We evaluated HLA DR3 transgenic (tg)
“humanized” mice as a potential model of ATR and assessed the possibility of using this animal model for tick
protective vaccine discovery studies. Serial tick infestations with pathogen-free Ixodes scapularis ticks were used to tickbite sensitize HLA DR3 tg mice. Sensitization resulted in a cytokine skew favoring a Th2 bias as well as partial (57%)
protection to infection with Lyme disease spirochetes (Borrelia burgdorferi) following infected tick challenge when
compared to tick na€ıve counterparts. I. scapularis salivary gland homogenate (SGH) and a group of immunoinformaticpredicted T cell epitopes identiﬁed from the I. scapularis salivary transcriptome were used separately to vaccinate HLA
DR3 tg mice, and these mice also were assessed for both pathogen protection and epitope recognition. Reduced
pathogen transmission along with a Th2 skew resulted from SGH vaccination, while no signiﬁcant protection and a
possible T regulatory bias was seen in epitope-vaccinated mice. This study provides the ﬁrst proof-of-concept for using
HLA DR tg “humanized” mice for studying the potential tick protective effects of immunoinformatic- or otherwisederived tick salivary components as tickborne disease vaccines.

Introduction
Ticks are found in almost every region of the world and are
second only to mosquitoes in their public health and veterinary
importance.1 However, ticks transmit the greatest variety of
human and animal pathogens of any arthropod vector, including
more than 20 emerging or Category A-C pathogens, all capable
of causing significant disease in humans.2 Few effective strategies
exist for protecting humans and animals against infection caused

by tickborne pathogens. Controlling ectoparasites of human and
veterinary importance still relies heavily on chemical pesticides;
however, effective and widespread chemical control of ticks suffers from development of resistance as well as human, animal, or
environmental safety concerns.
A sound public health approach for preventing tickborne
disease (TBD) would be to develop broad-spectrum vaccines
or other effective means that target vector arthropods and the
transmission process rather than every possible tickborne
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pathogen. Since most pathogens transmitted by ticks exhibit
some form of transmission delay following attachment, a protective vaccine would need to stimulate immune responses
during the early stages of feeding, prior to or soon after pathogen transmission commences.1,3,4 The delay for effective
transmission of pathogens, including the Lyme disease spirochete by nymphal Ixodes scapularis ticks is typically >24 hrs
and, at least in tick-bite sensitized hosts, innate immune cells
including basophils as well as CD4C (helper) T cell activity
can be activated before or soon after pathogen transmission
begins.5–7 T cells themselves are stimulated by a very limited
number of highly specific antigenic determinants (epitopes)
derived from the intruding organism’s proteins. Algorithms
that accurately model the MHC-peptide interface are central
to the prediction of T cell epitopes and are available for mice
and humans. Here, a “genes to vaccine” approach is applied
to I. scapularis tick salivary proteins for predicting epitopes
with immunogenic potential.
The concept of a tick protective vaccine has its foundation
in the naturally occurring phenomenon of acquired tick resistance (ATR). Non-natural tick hosts, such as Guinea pigs and
humans, demonstrate changes in their cell-mediated and
humoral immune response upon repeat infestations with pathogen-free ticks.8–10 Modification of cell-mediated immunity is
characterized by migration of basophils, neutrophils and eosinophils to the tick bite site with migration facilitated by T cells
and antibodies specific for tick salivary components.8,11 Recent
insights into the biology of basophils suggest their role as regulators of Th2 cell responses, through IL-4 expression or the differentiation of monocytes to macrophages.12 Th2 polarization
of the cytokine response to tick feeding has been observed both
in vitro and in vivo.13 Epidemiological and experimental evidence in animals and people shows that ATR can diminish or
prevent pathogen transmission.14,15 In fact, prior work has
demonstrated that tick bite-derived ATR in the Guinea pig
results in about 50–60% protection from Borrelia burgdorferi
infection upon infected I. scapularis tick challenge.15 Unfortunately, few reagents are available to fully characterize the
Guinea pig immune response to tick-bites. Repeat tick infestations in a number of laboratory mouse strains, including
BALB/c and C3H/HeN, result in significant polarization
toward a Th2 cytokine profile but without protection from
pathogen challenge or other evidence of ATR.16 It may be possible that transgenic mice, specifically those genetically altered
for human MHC II antigen presentation, could serve to fulfill
the need for an alternative model in studying the tick protective
response, as it would combine a ready availability of experimental reagents commonly exploited in mouse immunology studies
with naturally occurring ATR that correlates with B. burgdorferi
pathogen protection typically found in non-natural tick hosts.
Here, we report an evaluation of acquired tick resistance and
epitope-driven immune recognition for tick protective vaccine
development using tick-bite sensitized, whole tick salivary gland
homogenate (SGH)-immunized, and tick SGH peptide-immunized HLA DR3 transgenic mice.
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Results
Transgenic HLA DR3 mice as a model for acquired tick
resistance
We used 3 serial infestations with pathogen-free I. scapularis nymphs to tick-bite sensitize HLA DR3 transgenic
mice and C57BL/6 mice (B6); in this study, B6 mice serve
as the genetic background control. While the HLA DR4
allele does have a greater worldwide frequency, the rationale
for using the DR3 tg mouse model is founded upon the
global distribution of HLA DR3 in Northern and Western
Europeans and its coincidence with the worldwide distribution of B. burgdorferi (Bb), the causative agent of Lyme disease.17,18 All tick sensitized mice, along with an equivalent
number of tick na€ıve controls were subsequently pathogen
challenged by infesting each animal with 3–4 nymphal I.
scapularis derived from a cohort of Bb-infected ticks. Presence of Bb was confirmed by PCR in all challenge ticks
recovered (data not shown). Tick-bite sensitized HLA DR3
tg mice exhibited a longer tick engorgement period (Table 1)
and a partial (57%) protection to Bb infection (Table 2)
when compared to tick na€ıve HLA DR3 tg mice. Moreover,
Bb copy numbers from ear-punch biopsy samples were significantly lower (by 2.5-fold) in PCR positive, tick sensitized
HLA DR3 tg mice compared to their tick na€ıve counterparts. Altered tick feeding, either shortened or prolonged, is
indicative of host anti-tick responses. Grooming due to a
heightened itch response contributes to abbreviated tick
feeding.10 Prolonged feeding usually is associated with
increased pathogen transmission in tick-bite na€ıve hosts,
while extended feeding on a tick sensitized host occurs due
to an inability to obtain a proper bloodmeal. Primed host
immune defenses decrease vascular size and recruit neutrophils and lymphocytes to the tick bite site creating a hostile
environment for blood uptake and pathogen transmission.10,19 However, unlike ATR typically seen in other nonnatural tick hosts, there was no significant difference in the
amount of blood ingested by tick-bite sensitized HLA DR3
tg mice compared to tick na€ıve HLA DR3 or tick na€ıve or
sensitized B6 controls (Table 1).
Tick-bite sensitized HLA DR3 tg mice exhibited a cytokine
profile characteristic of a Th2 bias when compared with tick
na€ıve tg mice as demonstrated by IFNg and IL-4 ELISpot analysis (Fig. 1). Splenocytes derived from tick sensitized HLA DR3
tg mice and co-cultured with SGH to stimulate a recall response
expressed 3-fold average increase in IFNg production over
background (from ¡7 § 12 to 13 § 12 spot forming cells (SFC)
over background/106 cells) when compared to na€ıve counterparts. However, this increase remained below our criteria for
ELISpot positivity of 50 SFC per million cells above background
and was overshadowed by a significant 40-fold greater average
SFC in the IL-4 ELISpot. IL-4 production in sensitized HLA
DR3 tg mice ranged between ¡73 § 61 to 533 § 300 SFC over
background/106 cells, a significant 8-fold increase over naive
(Fig. 1).
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Table 1. Days to engorgement and engorgement weight of Ixodes scapularis nymphs fed on B6 and HLA DR3 tg mice during repeated infestations prior to
pathogen challenge. Data are expressed as mean § SD. Figures in parentheses are minimum and maximum values. Statistical signiﬁcance (P < 0.05) when
compared to HLA DR3 primary infestation data is denoted by *
Engorgement period (days)
Infestation

B6

3.9 § 0.4
3.5 § 0.8
(3.0–4.0)
(1.0–5.0)
n D 21
n D 35
4.1 § 0.5
4.2 § 0.9
(3.0–5.0)
(3.0–6.0)
n D 31
n D 36
4.1 § 0.5
4.2 § 0.8
(3.0–5.0)
(3.0–6.0)
n D 32
n D 37 *
Engorgement period (days)

1st

2nd

3rd

Borrelia challenge: tick-bite exposure
Na€ıve

Downloaded by [72.215.236.254] at 11:14 08 October 2015

HLA DR3

Sensitized

Engorgement weight (mgs)
B6

HLA DR3

3.2 § 1.1
3.8 § 1.0
(2.1–5.3)
(2.3–6.1)
n D 21
n D 35
3.1 § 1.5
3.4 § 1.3
(0.4–6.0)
(1.1–5.5)
n D 31
n D 36
3.5 § 1.0
3.3 § 1.1
(2.1–5.9)
(1.2–4.7)
n D 32
n D 37
Engorgement weight (mgs)

B6

HLA DR3

B6

HLA DR3

4.1 § 1.1
(1.0–6.0)
n D 36
3.8 § 0.7
(3.0–6.0)
n D 28

4.1 § 1.1
(1.0–6.0)
n D 36
3.8 § 0.7
(3.0–6.0)
n D 28

3.3 § 1.7
(0.3–5.5)
n D 29
3.8 § 1.3
(1.5–5.9)
n D 26

3.8 § 1.4
(0.3–5.6)
n D 36
3.6 § 1.2
(2.0–5.6)
n D 28

Immunization studies with whole tick SGH and selected
SGH component epitopes
In a second experiment, instead of serial tick feeding to sensitize HLA DR3 tg mice, we immunized mice with either whole
tick SGH or with selected T cell epitopes derived from immunoinformatic analysis of the I. scapularis salivary transcriptome.
Tick salivary components in the form of either whole SGH prepared from 18 hr fed, pathogen-free nymphal I. scapularis or a
pool of 11 immunoinformatic-predicted CD4C T cell epitopes
were administered intra-dermally as peptides formulated in liposomes (LLP) or without a carrier (NPP) and were followed by an
assessment of pathogen protection and immune recognition.
Prediction and in vitro validation of selected tick
SGH epitopes
Class II HLA epitopes were identified from the I. scapularis
salivary transcriptome using the EpiMatrix T cell epitope mapping algorithm combined with ClustiMer analysis.20,21 Table 3
shows the EpiMatrix cluster score for a group of epitopes selected
for synthesis because they were derived from salivary metalloproteases and other high abundance proteins in the transcriptome.22
Ninety percent of the selected peptides demonstrated cluster

scores >10, the threshold for predicted immunogenicity. Peptide
014 was the sole predicted epitope with a sub-threshold predictive score (8.88). Despite low predicted immunogenicity, peptide
014, was sourced from a salivary protein with fibrinolytic capabilities and a publication history suggesting its use as a vaccine candidate, and therefore was included in further testing.22,23 All 11
peptides were assayed in vitro for their capacity to bind multiple
HLA types including DRB1*0101, DRB1*0301, DRB1*0401,
DRB1*0701 and DRB1*1501. Fifty-five percent of the peptides
bound to at least 3 or 4 HLA alleles, and 36% bound to all 5. Of
the 55 peptide-HLA binding interactions assayed, 53% were
strong binders with high affinity, 11% moderate binders with
mid-level affinity and 36% with low to non-detectable affinity
(Table 3). The computational predictions and binding assay
results were evaluated with classification of peptide-HLA binding
pairs as either true positive, false positive, true negative or false
negative. Positive predictions were defined as epitopes in the top
5th percentile (scoring > 1.64 on the EpiMatrix z-scale) and
binding HLA at any affinity. Overall, the agreement with predictions, both positive and negative was 73%, which is consistent
with prior studies.24,25 With respect to each allele assayed, the
values are 55% for DRB1*0101, 64% for DRB1*0301, 45% for

Table 2. Infection status of B6 and HLA DR3 tg mice post Borrelia burgdorferi (Bb) challenge. qPCR results are expressed as mean § SD copies of Bb recA
genes normalized to 20,000 Mus musculus (Mn) nido genes. Figures in parentheses are minimum and maximum values. Statistical signiﬁcance (P < 0.05)
when compared to HLA DR3 na€ıve copy number denoted by *
Mouse strain
B6
HLA DR3

3050

Tick-bite exposure

Number infected / total challenged

qPCR detection of Bb

Na€ıve
Sensitized
Na€ıve
Sensitized

10/11
9/11
16/16
6/14

42.2 § 33.9 (0.0–120.2)
27.3 § 32.3 (0.0–103.2)
81.9 § 93.2 (0.0–382.7)
31.8 § 49.6 * (0.0–212.9) p < 0.001
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vaccinated mice as measured by qPCR Bb gene copy number was
significantly lower (p D 0.038). Bb copy numbers within control
vaccinated mice were 14-fold greater (55.9 § 68.4) than the average 3.9 § 4.7 copies detected in SGH-vaccinated HLA DR3 tg
mice. NPP- and LPP-immunized mice exhibited mean Bb gene
copy numbers of 22.1 § 30.9 and 34.4 § 23.1, respectively
(Table 4). All SGH- and peptide-immunized mice had at least 2
infected challenge ticks that attached and fed for longer than 24
hrs, which is adequate to assure Bb transmission.7

Figure 1. Ex vivo recall IFNg and IL-4 responses stimulated by salivary
gland homogenate (SGH) in tick na€ıve () and tick-bite sensitized ()
HLA DR3 tg mice. SGH was assayed for T cell reactivity by IFNg and IL-4
ELISpot assay using splenocytes isolated from mice. Data are the mean
spot-forming cells (SFC) over background per million splenocytes that
secrete cytokines in response to SGH. Individual subject average
responses are represented by dots and the mean cytokine responses
across all subjects by white bars. The 50 SFC over background per million
splenocytes cutoff is denoted by the dotted line. Statistical signiﬁcance
(P < 0.05) is noted by *.

DRB1*0401, 64% for DRB1*0701, and 91% for DRB1*1501.
Discrepancies between positive predictions and actual binding
include peptide folding, peptide aggregation under assay conditions, or the predictive accuracy of immunoinformatic algorithms. A large, retrospective comparison of the EpiMatrix with
epitope mapping algorithms in the public domain showed that
EpiMatrix was >75% accurate across all the HLA Class II alleles
studied here, which is as accurate as or more accurate than other
epitope prediction tools.26 It is likely that a significant part of the
discrepancy between predictions and HLA binding is due to peptide design and physical properties.
Borrelia pathogen challenge of SGH and epitope-immunized
transgenic mice
Neither SGH- nor epitope-immunized HLA DR3 tg mice
were completely protected from Bb infection when challenged by
Bb-infected ticks and compared with control vaccinated animals.
Although 100% infection rate is the “expected” outcome of the
challenged control animals, observed results differed for the aberrant mouse due to uncharacteristic and excessive grooming resulting in early removal of ticks. The majority of mice in each
vaccination arm did have detectable levels of Bb genes in ear
punch biopsies (Table 4). However, similar to the tick-bite sensitized HLA DR3 tg mice, the level of Bb infection in the SGH-

www.landesbioscience.com

Epitope-specific IFNg and IL-4 responses in tick-bite
sensitized transgenic mice
To begin dissecting the nature of the immune response to tick
salivary components, splenocytes from both tick na€ıve and tickbite sensitized HLA DR3 tg mice were evaluated for antigen-specific immune recall. Cells were stimulated with either whole
SGH or individual peptides for measurement of IFNg and IL-4
production by ELISpot assay. Only 2 peptides stimulated a differential response in tick sensitized mice when compared with
their tick na€ıve counterparts (Fig. 2). Peptide 014 appeared to
stimulate IFNg production greater than 50 SFC per million splenocytes in sensitized HLA DR3 tg mice (Fig. 2A) with a 3-fold
increase of 20 § 14 mean SFC over background in na€ıve mice to
81 § 13 in tick sensitized mice. However, this epitope was predicted to be a weak/non-binder for HLA DR3 (Table 3) and
may represent a spurious result. Differential IL-4 production
among tick sensitized mice was only observed for peptide 017
(Fig. 2B). Interestingly, tick sensitized mice demonstrated a significant decrease in production of IL-4, with a mean of ¡7 § 30
SFC over background compared to a mean of 79 § 42 SFC for
tick na€ıve mice. While we did expect to see a greater number of
individual peptide stimulations result in more robust IL-4 production among tick-bite sensitized mice, similar to what was
observed following whole SGH stimulation (Fig. 1), from these
results we can speculate that tick-bite sensitization stimulates T
cells with different epitope specificities, and that the epitopes
selected for this trial were not immunodominant.
IL-4 production in SGH- and peptide-immunized
transgenic mice
To better determine the antigenic potential of in silico-predicted tick SGH epitopes, individual peptide stimulations were
screened by IL-4 ELISpot assay, as above, but using splenocytes
derived from control-, whole SGH- and peptide-immunized
HLA DR3 tg mice prior to pathogen challenge. Splenocytes
from SGH-immunized mice restimulated with SGH demonstrated >6-fold increase in IL-4 production compared with control-vaccinated mice (P D 0.015) (Fig. 3). Specifically IL-4
production in control HLA DR3 tg mice exhibited a mean of
¡48 § 78, while cytokine production in SGH-immunized mice
peaked at 669 SFC with mean IL-4 production of 259 § 263
SFC. Stimulation of splenocytes from SGH-immunized mice
using either the peptide pool or individual peptides yielded minimal production of IL-4, never greater than 50 SFC per million
typically considered to be a positive response.
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Table 3. HLA DR binding afﬁnities for selected immunoinformatic-predicted
Ixodes scapularis salivary epitopes. Coded peptide identiﬁers and predicted
immunogenicity (EpiMatrix cluster score) are noted in the ﬁrst 2 columns,
respectively. Column 4, *0301, represents the allele found in the DR3 transgenic mouse model. IC50 values in mM units were calculated from curves ﬁtted to dose-dependence competition binding data for each peptide-HLA
DR allele pair. Peptide binding afﬁnity is shown according to the following
classiﬁcation: IC50 < 10 mM (black), 10 < IC50 < 100 mM (dark gray), IC50 >
100 mM (light gray)
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Peptide

EpiMatrix
Cluster
Score

003

36.44

004

22.48

005

21.82

006

19.61

014

8.88

017

29.86

018

26.17

019

25.2

022

24.04

023

18.96

024

18.27

HLA CLASS II Allele IC50
*0101

Weak/Non Binder
IC50>100

*0301

*0401

Moderate Binder
10<IC50<100

*0701

*1501

Strong Binder
IC50<10

In mice immunized using the peptide pool (LPP and NPP),
re-stimulation using either the peptide pool or individual peptides resulted in mean IL-4 production greater than 50 SFC per
million for 8 out of 11 (73%) individual epitopes as well as the
peptide pool, although results varied somewhat depending on
whether the peptides were incorporated into liposomes (LPP) or
were immunized as naked peptides (NPP)(Fig. 3). Recognition
of the peptide pool yielded a significant 6-fold increase in production of IL-4 (mean D 194 § 177 SFC) in NPP-immunized
mice when compared to the SGH-immunized arm (P D0.005).
In individual peptide stimulations, epitopes 003, 004, 014, 017,
018, 022, 023 and 024 all stimulated a mean greater than 50
SFC per million cells in LPP-vaccinated HLA DR3 tg mice,
while only 3 of these 11 epitopes (004, 017 and 023) stimulated
a mean more than 50 SFC per million cells in NPP-vaccinated

mice, suggesting that peptide formulation in liposomes enhanced
immunogenicity. One of these epitopes, 004, produced
3£ increased SFC (mean D 98 § 28 SFC) in LPP-vaccinated
mice than in SGH-vaccinated mice (mean D ¡51 § 85 SFC),
which was a significant result (P D0.023). Peptide 004 was predicted to be a strong HLA DR3 binder. Five of the 8 epitopes
that produced greater than 50 SFC per million in LPP-vaccinated
mice were predicted to be either strong or moderate HLA DR3
binders, validating HLA binding as a pre-screening tool for epitope selection in future tick protective vaccine studies using HLA
transgenic mice. Interestingly, mice immunized with the peptide
pool either with and without liposomal carrier, did not respond
to stimulation with whole SGH.
Three peptides (005, 006, and 019) failed to stimulate any
significant IL-4 responses. The small cohort size of the study and
restricted HLA background may explain this result. Alternatively,
these sequences may stimulate helper T cell cytokines other than
IL-4.
Cytokine profile of SGH and peptide-immunized
transgenic mice
Concurrent characterization of TH1/TH2/TH17 cytokine
profiles of immunized mice following prolonged (24, 48 and 72
hrs) co-culture with ConA, SGH and pooled peptides was
assayed by cytokine bead array. Figure 4 displays 48 hr co-culture
data which appeared to be the optimal incubation timepoint for
cytokine expression. Co-culture with stimulants for 72 hrs
resulted in little to no response possibly because of cell exhaustion
due to prolonged stimulant exposure (data not shown). Co-culture with ConA served as positive control for this assay and
although results varied for each cytokine in the panel (lowest IL4 @ 16 pg/mL; highest IFNg @ 260 pg/mL), for every cytokine
assayed, concentrations (pg above background) were consistent
between each of the experimental arms (data not shown).
Not surprisingly, Th2-associated cytokines IL-4 (6 pg/mL)
and TH17-predominant IL-6 (62 pg/mL) were the main cytokines stimulated by SGH in SGH-immunized HLA DR3 tg
mice, comprising 98% of the overall response in this vaccination
arm (Fig. 4A). Mean IL-6 production stimulated by SGH in the
SGH-immunized mice was 41-fold greater than the control
immunization group while mean IL-4 production was 6-fold
greater than in the control vaccine arm. IL-10 (20 pg/mL) and
TNF (12 pg/mL) were the dominant cytokines expressed by
NPP-vaccinated mice when re-stimulated with SGH representing
60% of the overall response (Fig. 4A). The remainder of the
overall cytokine response stimulated by SGH in NPP-immunized

Table 4. Infection status of SGH- and peptide-vaccinated HLA DR3 tg mice post Borrelia burgdorferi (Bb) challenge. qPCR results are expressed as mean § SD
copies of Bb recA genes normalized to 20,000 Mn nido genes. Figures in parentheses are minimum and maximum values. Statistical signiﬁcance (P < 0.05)
when compared to control vaccinated HLA DR3 tg mice copy number denoted by *
Vaccination Arm
Control
SGH
Peptide Pool (NPP)
Liposomal Peptides (LPP)

3052

Number infected / total challenged

qPCR detection of Bb

3/4
3/4
4/4
4/4

55.9 § 68.4 (0.0–176.9)
3.9 § 4.7 * (0.0–11.1)
22.1 § 30.9 (0.0–72.8)
34.4 § 23.1 (0.0–63.3)
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Discussion
Since its discovery by Trager in 1939,
acquired resistance to tick feeding has been
extensively studied in laboratory animals.27
Repeated tick infestations of Guinea pigs
and various murine strains act as separate
puzzle pieces that when combined, provide
an expanding picture of the features of tickhost interactions. Traditionally ATR was
identified by the effect on the tick: altered
feeding duration, decreased engorgement
weight, reduced production and viability of
ova, and inhibition of molting.28 Observations of ATR in the Guinea pig model also
has provided insight into the role of basophils at the host cutaneous bite site.8 Even
more, partial protection from Borrelia challenge seen in tick sensitized Guinea pigs
provided evidence that potential vaccine
candidates reside in the complex cocktail of
tick saliva.15 Though first identified in
Guinea pigs, the Th2 bias of repeated tick
infestations was best represented by gene
expression and cytokine profile studies in
BALB/c, C3H/HeN and C3H/HeJ murine
strains. 29-32 However, in those mouse
models, repeat tick exposure induced
immune response changes but neither
BALB/c nor C3H/HeN mice developed
resistance.16,33-35
Here, we have presented data that supports adding HLA DR3 transgenic mice to
the list of model organisms for acquired tick
resistance and tick protective vaccine discovery research. Of course, further characterizaFigure 2. Ex vivo recall IFNg (A) and IL-4 (B) cytokine responses in tick na€ıve () and tick-bite sensition of these “humanized” transgenic mice
tized () HLA DR3 tg mice stimulated by SGH and individual tick salivary peptides predicted by
exposed to repeat tick infestations is needed,
immunoinformatics. Data are the mean spot-forming cells (SFC) over background per million spleincluding expanding the model to include
nocytes that secrete cytokines in response to SGH or individual epitopes in IFNg and IL-4 ELISpot
other transgenic (e.g., DR4) murine strains.
assays. Individual subject average responses are represented by dots and the mean cytokine
responses across all subjects by white bars. The 50 SFC over background per million splenocytes
Future studies could examine the effects of
cutoff is denoted by the dotted line. Statistical signiﬁcance (P < 0.05) is noted by *.
ATR in HLA tg mice on molting success and
egg production but most certainly should
include a deeper characterization of the
CD4C T cell response to tick salivary commice was generally distributed across the other cytokines assayed.
SGH-stimulated cells from either control or LPP-vaccinated ponents. Assessing the role of antibodies to tick salivary proteins,
especially IgE, and characterizing cellular infiltrates at the tick bite
mice expressed little to no response in the CBA assay.
The predominant peptide pool-stimulated cytokine response site would likely yield additional immune correlates to the nearly
in cells from peptide-vaccinated mice was IL-10 which comprised 60% protection against Bb infection that we recorded. However, the
37% of the total measured cytokine response in NPP-vaccinated strong Th2 bias present in the tick-bite sensitized IL-4 ELISpot stud(25 pg/mL) mice and 76% of the response in LPP-vaccinated ies linked with our observed 57% protection from Borrelia pathogen
mice (32 pg/mL). The remainder of the overall cytokine response challenge, suggests that the HLA DR3 tg mouse model appears
stimulated by the peptide pool was fairly evenly distributed across capable of bridging the previously useful Guinea pig ATR model
the other cytokines assayed. Peptide pool-stimulated cells from and well-established murine models commonly used in immunoleither control or SGH-vaccinated mice expressed little to no ogy and early vaccine discovery studies. The off-the-shelf availability
of resources and reagents for the murine model is one compelling
cytokine response.
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reason for adopting “humanized” mice for
tick protective vaccine development studies.
Moreover, the presentation of human MHC
II antigen in the context of the mouse model
brings the HLA DR3 tg mouse model closer
to the human perspective, which is an added
benefit for vaccine discovery research.
As noted above, any vaccine-mediated
tick protective response would likely need
to be stimulated during the early stages of
tick feeding, prior to or soon after pathogen transmission commences.1,3,4 With
this key concept in mind, splenocytes from
tick-bite sensitized and SGH- or peptidevaccinated HLA DR3 mice were re-stimulated with SGH that had been prepared
from salivary glands harvested from
nymphal I. scapularis early (18 hr) in the
Figure 3. Antigen-speciﬁc HLA DR3 tg mouse IL-4 responses stimulated by tick SGH and immutick feeding process. Additionally, during
noinformatics-predicted tick salivary epitopes in control-, SGH-, and peptide-vaccinated mice.
immunization studies, tg mice were immuWhole SGH, peptide pool and individual epitopes were assayed for T cell reactivity by IL-4 ELISpot
nized with 18 hr SGH. Salivary gland disassay using splenocytes isolated from vaccinated mice. Data are the mean spot-forming cells (SFC)
section and collection parameters are
over background per million splenocytes that secreted cytokines in response to antigen-speciﬁc
noteworthy due to the dynamic nature of
stimulation. Individual subject average responses from experimental vaccination arms are represented as: control immunizations (&), SGH immunizations (), naked peptide pool (NPP) immunigene expression in the tick salivary tranzations (~), liposomal peptide pool (LPP) (5). The mean cytokine responses across all subjects are
scriptome, and the desire to concentrate
represented by white bars. The 50 SFC over background per million splenocytes cutoff is denoted
on vaccine candidates present during early
by the dotted line. Statistical signiﬁcance (P < 0.05) is noted by *.
feeding, prior to pathogen transmission.
Previous studies have even suggested that
tick salivary proteins expressed prior to 24 hrs are sufficient to the extent of Th2 polarization and pathogen protection by SGH or
induce, at least a partial tick protective immunity. 5,7,36
peptide vaccination was inferior to that seen in experimental tickEmpirical evidence of ATR in Guinea pigs subjected to repeat bite sensitizations, this study is proof of concept that in searching
infestations with the tick Rhipicephalus sanguineus, demonstrated for a tick protective vaccine, the transgenic mouse model is worth
that experimental tick infestations were superior to vaccination exploring further with immunoinformatic-predicted tick salivary
with unfed, crude, whole tick extract.37 Likewise, our own studies epitopes.
showed that the protective response to Bb pathogen challenge folThe cytokine response in peptide-vaccinated mice was not
lowing immunizations with 18 hr SGH proved not as effective as coordinated into a distinct Th1 or Th2 response as evident in the
when induced by repeat I. scapularis infestations. Tg mice immu- multiplex CBA data (Fig. 4). This non-polarized, IL-10 dominized with SGH did have significantly fewer copies of Bb in ear nant immune response to peptide immunizations may explain
punch biopsies than control animals, but the pathogen infection the lack of protection upon pathogen challenge. Indeed, the
rates between the 2 groups of animals were similar. The IFNᵧ ELI- CBA data from NPP-immunized mice co-cultured with pooled
Spot assays documented 3x more spots over background in tick- peptides (Fig. 4B) suggests conflicting immune responses driven
bite sensitized mouse splenocytes re-stimulated with SGH when by anti-inflammatory cytokine IL-10 and pro-inflammatory ILcompared to their control counterparts. The IFNᵧ response of tick- 4, IL-6 and TNF. It is highly likely that a different pool of tickbite sensitized DR3 mice, though significant, is eclipsed when com- derived peptides would yield a cytokine profile that is Th2pared to the 40-fold higher average IL-4 response to co-culture with focused. Since our findings point to a Th2 correlate of protection
SGH. Differential production of IL-4 between tick-bite sensitized with a predominant IL-4 cytokine response, future studies will
and tick-bite na€ıve DR3 mice showed >8 -fold difference using focus on identifying and immunizing the HLA DR3 tg mice
similar assay conditions. The lower level of protection (reduced Bb with peptides that drive a more robust IL-4 response.
gene copy numbers, Table 4) afforded by SGH-vaccination also
Increased production of IL-10 in response to tick saliva is a well
was correlated with the well documented Th2-polarized cytokine characterized aspect of repeat tick infestations.31,39 Our data in the
response to tick saliva. We noted by CBA, increased levels of IL-4, HLA DR3 mouse supports and expands these findings showing
IL-10 and IL-6 in SGH-immunized co-cultures in agreement with high levels of IL-10 production in NPP-immunized mice in
Titus’s review of the immune-modulatory factors of I. scapularis response to co-culture with SGH as well as the peptide pool
saliva.38 We also demonstrated that, in the best case, 8/11 epitopes (Fig. 4A and B). IL-10 is a multifunctional anti-inflammatory cytodrawn from the I. scapularis salivary transcriptome stimulated an kine that dampens the inflammatory response and helps prevent tisIL-4 recall response post peptide pool-vaccination (LPP). Albeit, sue damage. Its role in a T regulatory manner has been suggested
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epitopes into TCR-facing residues and
HLA-facing residues, and then compares
the TCR face to other putative T cell epitopes in the human genome. JanusMatrix
defines cross-reactive T cell epitopes as
those that have the same MHC allele
restriction, the same or similar T cell-facing residues (epitope), and conserved
binding of MHC-facing residues (agretope).40 JanusMatrix analysis reveals that
there are 9-mers in peptide 017 that share
a TCR face with 10 human 9-mers. However, this analysis should be viewed conservatively, since JanusMatrix screens for
homology against the human and not the
murine genome. Regardless, the potential
T regulatory role of tick saliva and salivary
components is an interesting and likely
necessary new frontier requiring consideration in going forward with tick protective
vaccine research in both the novel HLA
DR3 tg mouse model and humans. The
JanusMatrix algorithm makes it possible
to pre-screen candidate sequences for
potential Treg activation to carefully select
tick salivary protein epitopes that will support a Th2-focused immune response for
better epitope-based vaccine design in the
future.

Methods
Predicting immunogenic peptides
from the I. scapularis salivary
transcriptome with EpiMatrix and
ClustiMer analysis
EpiMatrix is a T cell epitope-mapping
algorithm used to identify putative HLA
ligands/T cell epitopes contained within
protein sequences (e.g., epitopes identified from pathogen genomes).41,42
Unlike previous EpiMatrix analyses of
genomes, the tick salivary transcriptome was used as the input
sequence and subsequent source of epitope peptides.21 Computation was performed by using a set of HLA allele-specific coefficient matrices. To complete an analysis using the EpiMatrix
algorithm, target protein sequences were parsed into overlapping
9-mer frames in which each frame overlaps the last by 8 amino
acids. Each amino acid in the 9-mer was then assigned a positive
or negative coefficient based on its previously determined propensity to positively or negatively impact peptide binding when
located at that amino-acid position within the HLA-binding
groove.43 The coefficients were then summed to produce a raw
score for each 9-mer. Raw scores were normalized with respect to
a distribution derived from a large set of randomly generated

Figure 4. Multiplex cytokine bead array (CBA) proﬁle of splenocytes from vaccinated HLA DR3 tg
mice co-cultured for 48 hrs either with whole SGH (A) or the tick salivary epitope peptide pool (B)
used in 2 of the experimental vaccination arms. Data are concentrations of cytokines in picograms
(pg/mL) above background elicited by splenocytes in response to antigen-speciﬁc stimulation. Values
of zero are represented below the x-axis as no response (NR). Vaccination arms are represented as:
Control vaccination arm- lightest gray, SGH immunization arm- white, NPP vaccination arm- dark
gray, LP immunization arm- black. Control splenocytes were co-cultured with medium C adjuvant
alone resulting in cytokine production below 12 pg/mL for all monitored cytokines (data not shown).

only recently during transcriptional profiling of repeat tick infestations of BALB/c mice in which up-regulation of IL-10 and FoxP3
was monitored at the tick-bite site 29. It may be that immunizations
with the selected immunoinformatic-derived peptides induced a T
regulatory response, accountable for the considerable IL-10 accumulation and lack of protection from pathogen challenge. One particular peptide within the pool, peptide 017, with its significantly
lower IL-4 production in tick-bite sensitized tg mice compared to
na€ıve mice (Fig. 2B) suggests a potential regulatory function which
may have influenced the immunization results. Post hoc in silico
analysis of this epitope for possible TCR-face homology with
human (self) sequences was performed using JanusMatrix, a novel
algorithm developed after the tick salivary antigen epitopes were
identified.40 JanusMatrix parses the amino acid sequence of T cell
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peptide sequences. The resulting Z-scores from this distribution
were directly comparable across predictions for different alleles.
ClustiMer identified “clustered” or promiscuous epitopes.44,45 Potential T cell epitopes are not randomly distributed
throughout protein sequences but instead tended to “cluster” in
specific regions. T cell epitope “clusters” range from 9 to
roughly 25 amino acids in length and, considering their affinity
to multiple alleles and across multiple frames, could contain
anywhere from 4 to 40 binding motifs. Class II epitope selections for vaccine design were usually limited to selected
“promiscuous epitopes” – epitopes that had the potential to be
recognized in the context of more than one HLA. EpiMatrix
ClustiMer scores above 10 were considered to be immunogenic.
Peptide synthesis and HLA binding assay
All peptides used in this study were synthesized by 9-fluoronylmethoxy-carbonyl (Fmoc) synthesis to a purity of >80% as
determined by HPLC by 21st Century Biochemicals (Marlborough, MA, USA). The peptide masses were confirmed by
MALDI-TOF mass spectrometry.
Peptides were assayed for HLA affinity in a competition binding assay based on Steere et al.46 In 96-well plates, a test peptide
and a reference peptide compete for binding to a purified class II
HLA molecule (Benaroya Research Institute) for 24 h at 37 C.
Non-biotinylated test peptides were evaluated over a wide range
of concentrations (0.01–200 mM) while biotinylated standard
peptide was held at a fixed concentration (0.1 mM). Peptide-class
II HLA complexes were then captured on ELISA plates using pan
anti-HLA-DR antibody (L243, BioXCell). Plates were washed
and incubated with Europium-labeled streptavidin (PerkinElmer) for one hour at room temperature. Europium activation
buffer was added to develop the plates for 15–20 min at room
temperature before they were read on a Time Resolved Fluorescence (TRF) plate reader. All assays were performed in triplicate.
Dose dependence curves were generated by fitting data using the
4-parameter logistic equation, and IC50 values were calculated in
SigmaPlot 11.0 (Systat). Based on the IC50 values, peptide binding to a given HLA allele was classified as high affinity (1–
10 mM), moderate affinity (10–100 mM), low affinity
(>100 mM). Peptides that did not inhibit the binding of the biotinylated reference peptide at any concentration were considered
non-binders. Binding assays were performed for 5 alleles:
DRB1*0101, DRB1*0301, DRB1*0401, DRB1*0701, and
DRB1*1501, providing a broad representation of class II HLA
allele binding pockets.47
Experimental animals
Six to 14 week-old female C57BL/6 mice (B6) were purchased from Harlan. HLA DR3 transgenic mice on a C57BL/6
background were obtained from Dr. Chella David (Mayo Medical School) under MTA. The mice express the HLA DR3a and
b genes on a B.10-Ab0 mouse background and were back-crossed
over 6 generations with class II-negative on a C57BL/6 background.48 Specifically, DRBI*0301 (DR3) transgenic mice were
generated by co-injection of an HLADRa genomic fragment and
a DRB1*0301b gene fragment into (C57BL/6 X DBA/2)F1 X
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C57BL/6 embryos and backcrossed to B10 mice as detailed previously.49 The DR3 transgene was first introduced into B10.M
mice at the Mayo Clinic by repeated backcrossing. Subsequently,
the DR3 gene was introduced into the class II-negative H2A0
strain by mating the B10.M-DRBI*0301 line with the B10.Ab0
line, similar to the strategy detailed previously for HLADQ transgenic mice.50,51 All studies were performed in full compliance
with the standards of the University of Rhode Island Institutional
Animal Care and Use Committee and in accordance with NIH
publications entitled “Principles for Use of Animals” and “Guide
for the Care and Use of Laboratory Animals.”
Tick rearing and salivary gland homogenate
Ixodes scapularis ticks were reared using standard methods.4
Adult ticks were collected from nature to create immature tick colonies. One hundred larvae from each egg batch were screened by
PCR using pathogen-specific primers for Borrelia burgdorferi and
Borrelia miyamotoi. Certified pathogen-free larval stage ticks were
blood fed on hamsters or white-footed mice. To generate Bbinfected nymphs, pathogen-free larvae were allowed to feed on
white-footed mice previously infected with the B31 strain of B.
burgdorferi, and were then held until molting. Such methods generally yield >90% Bb infectivity. All unfed ticks were maintained
at 23 C and >90% relative humidity under 14 h light/10 h dark
photoperiod before infesting hosts. Methods for generating and
maintaining Bb-infected and uninfected tick colonies, including
animal care, followed approved URI IACUC protocols.
Pathogen-free nymphs were allowed to feed for 18–20 hours
prior to dissection for salivary glands. Partially fed ticks were dissected in ice-cold phosphate buffered saline (PBS) within 4 hrs of
being removed from the host animal. After removal, glands were
washed in the clean buffer and tissues were stored at ¡70 C in PBS
until cell lysis by sonication. Protein concentration was detected by
UV nanodrop quantification (ThermoScientific, ND-1000).
Tick-bite sensitizations
Tick-bite sensitizations
Prior to each infestation, animals were anesthetized by IP
injection of ketamine (20mg/mL) (Vedco, NDC50989-161-06)
and xylazine (2mg/mL) (Lloyd Laboratories, 4821) and placed in
stainless steel, quarter-inch wire mesh tubes for up to 3 hours.
Tick attachment was assessed by counting attached ticks 2 hrs
after placement. At this time, all but 3 attached ticks were
removed in an effort to minimize “sharing” of tick salivary
immunosuppressive proteins. By selective removal, the 3 ticks
that remained attached were distributed as far apart as possible. A
total of 14 HLA DR3 and 11 B6 mice were sensitized to tick
bites 3 times using pathogen-free nymphs attached for 72 hrs.
Tick feedings occurred at 2 week intervals. Additionally, groups
of 16 HLA DR3 and 11 B6 mice acted as non-tick sensitized
(tick na€ıve) controls. Biologic data related to tick feeding
(engorgement weight and days to engorgement) were analyzed by
Kruskal-Wallis ANOVA of Variance on Ranks and the means
compared by Dunn’s test (P < 0.05) (SigmaPlot).
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Pathogen challenge
Two weeks following the 3rd infestation, mice, including
na€ıve controls, were challenged with 3 Bb-infected nymphs. All
animals were monitored daily, and tick feeding parameters (duration of attachment, total recovered engorged, and engorgement
weight) were recorded. Animals subjected to Bb challenge were
allowed to rest for 4 weeks to allow for dissemination of bacteria.
Detection of Borrelia infection
The Bb infection status of each animal was assessed 4 weeks
following infected tick challenge by direct PCR assay of ear
punch biopsy. Positive infection status of an animal was determined if Borrelia specific genes were amplified from ear punch
samples by quantitative PCR.
Total genomic DNA was extracted from ear punches using the
DNeasy Blood and Tissue kit (Qiagen, 69504) according to
manufacturer’s protocol. Additionally, DNA was extracted from
a non-infected mouse ear punch and a culture of Bb strain B31
for qPCR standard generation. Primers amplifying mouse nido
were used as a reference gene during simultaneous detection of
Bb recA gene. The oligonucleotide primers used to detect mouse
nidogen were nido.F 50 -CCA GCC ACA GAATAC CAT CC-30 ,
and nido.R 50 -GGA CT ACT CTG CTG CCATC-30 .52 The
oligonucleotide primers used to detect Bb recA were nTM17.F
50 -GTG GAT CTATTG TAT TAG ATG AGG CTC TCG-30
and nTM17.R 50 -GCC AAA GTT CTG CAA CAT TAA CAC
CTA AAG-30 .53 Real-time quantitative PCR (qPCR) was performed using an Mx4000 Multiplex Quantitative PCR System
(Stratagene, La Jolla CA). Quantitation of DNA copy number
was performed using Brilliant SYBR Green qPCR Master Mix
(Agilent, 600828) with 10 ng of total DNA in 50 ml reactions.
Thermal profile was 95 C for 15 min then 40 cycles of 95 C for
30 s and 55 C for 1 min and 72 C for 1 min. Fluorescence was
measured at the end of the 55 C step every cycle. Samples were
run in experimental duplicate with inter-plate and no template
controls. SYBR threshold was locked at 0.010 with ranges of efficiency between 95–100%. Copies of Bb recA genes were normalized against 20,000 copies of mouse nido genes. Samples were
determined to be unifected if no Bb recA genes were detected in
either duplicate, as indicated by “No CT value." Positive infection status was recorded if Bb recA genes were identified in either
one or both duplicates. Copy number data were analyzed by
Kruskal-Wallis ANOVA of Variance on Ranks and the means
compared by Dunn’s test (P < 0.05) using SigmaPlot software.
ELISpot detection of cytokine production in HLA DR3 tg mice
The frequency of epitope-specific splenocytes was determined
by IFNgand IL-4 ELISpot assay using the Mabtech IFN-gamma
(Mabtech, 3321–4HPT-4) or IL-4 (Mabtech, 3311–2HW-Plus)
ELISpot Kits according to the manufacturer’s protocol (Mariemont, OH). Briefly, spleens were harvested from groups of naive
and sensitized HLA DR3 transgenic mice and mascerated to produce single cell splenocyte suspensions in RPMI–10% (Fisher,
SH30027 FS) fetal bovine serum–1% (Thermo Scientific,
SH3007003HI) penicillin/streptomycin–1% (Lonza, 17602E) Lglutamine–0.1% (MP Biomedicals, 091680149) and BME
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(Sigma Aldrich Aldrich, M6250–10ML) at a concentration of
1.5 £ 106 cells/mL. Cells were transferred at 1.5 £ 105/well to
ELISpot plates pre-coated with anti-murine IFN-gamma by the
manufacturer. IL-4 plates were not pre-coated and were prepared
24 hrs in advance according to manufacturer’s specification. Cells
were stimulated with SGH at 20 mg/mL in triplicate wells and
individual peptides at (20 mg/mL also in triplicate). Cells co-cultured with ConA (2 mg/ml) (Sigma Aldrich, C5275–5MG)
acted as positive controls while cells stimulated with no peptide
(PBS only) served as a negative control. ELISpot plates were
incubated at 37 C, 5% CO2 for 18 hours, washed, incubated
with a secondary HRP labeled anti-IFN-gamma antibody or
anti-IL-4 antibody and developed by addition of TMB substrate.
Raw spot counts were recorded by a CTL S5 UV ELISPOT
reader. Results were recorded as the mean number of SFC over
background and adjusted to spots per one million cells seeded.
Responses to stimulations are considered positive if the number
of spots are: 1) at least twice greater than background, 2) greater
than 50 spot forming cells per one million splenocytes over background (i.e. one response over background per 20,000 splenocytes), and 3) statistically significant by Wilcoxon Signed Rank
Test in comparison with the corresponding spot forming cell
data set for other groups (p < 0.05) using SigmaPlot software.
Immunization of HLA DR3 transgenic mice
Prior to each immunization, animals were anesthetized by IP
injection of ketamine (20mg/mL) and xylazine as previously
stated.
A control group of 8 HLA DR3 tg mice were immunized
intra-dermally with saline and Imject AlumÒ adjuvant (ThermoScientific, 77161) in 1:1 ratio for a total inoculation of 100 mL
on 3 occasions over 4 weeks (days 0, 14, 25).
A group of 9 HLA DR3 transgenic mice received intra-dermal
immunizations of 50 mg/100 mL of SGH with 50 mg/100 mL of
adjuvant on 3 occasions over 4 weeks (days 0, 14, 25).
A group of 8 HLA DR3 transgenic mice were immunized
intra-dermally with a pool of tick salivome predicted peptides, in
equal representation, and a 1:1 ratio of adjuvant for a total of
50 mg peptide/100 mL dose on 3 occasions over 4 weeks (days 0,
14, 25). This immunization arm was referred to as naked peptide
pool (NPP).
A group of 9 HLA DR3 transgenic mice received intradermal
immunizations of liposomal formulated peptides and an equal
volume of adjuvant in 100 mL on 3 occasions over 4 weeks (days
0, 14, 25). This immunization arm was referred to as peptide
pool in liposomes (LPP). Sterically stable cationic liposomes were
prepared from 3 lipid components: dioleylphosphatidylethanolamine (DOPE), dimethylaminoethane-carbamoyl-cholesterol
(DC-cholesterol), and polyethylene glycol 2000-phosphatidylethanolamine (PEG). The lipids were mixed in chloroform, dried
in a rotary evaporator, and re-suspended in phosphate-buffered
saline (PBS) to make empty multi-lamellar vesicles. These vesicles
were sonicated 5 times for 30 seconds each at 4 C to convert
them into multi-lamellar liposomes. Multi-lamellar liposomes
(10 nmol) were mixed with peptides, flash frozen, and freezedried overnight. To encapsulate peptides in liposomes, the
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resulting powder was re-suspended with sterile distilled water and
vortexed for 15 seconds every 5 minutes for 30 minutes at room
temperature. PBS was added to yield a final liposome concentration of 10 mM lipid/mg peptides. Vesicles <150 nm in diameter
were produced by 20–30 cycles of extrusion through polycarbonate filters using a Lipofast extruder (Avestin, Canada). Liposome
formulations were stored at 4 C until use.
Cytokine profile detection of immunized HLA DR3 mice
At day 42, 4-5 mice from each immunization arm were euthanized to determine the effect of immunizations on cytokine production. The frequency of epitope-specific splenocytes was
determined by IL-4 ELISpot assay using methods as previously
stated with the following differences. Post immunization, spleens
were harvested from control immunization groups and groups of
HLA DR3 tg mice immunized to SGH, NPP and LPP. Cells
were enumerated and plated as previously stated. Cells were cocultured with SGH at 20 mg/mL in triplicate wells, pooled peptides, PP (20 mg/mL) and individual peptides (20 mg/mL). Cells
stimulated with ConA (2 mg/ml) acted as positive controls while
cells stimulated with PBS (no peptide) served as negative controls. ELISpot plates were incubated at 37 C, 5% CO2 for
18 hours. Washing, detection and spot detection was completed
as previously stated. Positive response criteria for ELISpot analysis remains as previously stated, however statistical significance is
determined by Kruskal-Wallis ANOVA of Variance on Ranks
with post-hoc Dunn’s test in comparison with the corresponding
spot forming cell data set for other groups (P < 0.05).
Additionally, cytokines were simultaneously monitored by
cytokine bead array (CBA) according to manufacturer’s specifications using the BD Bioscience Th1/Th2/Th17 kit and
appropriate standards (BD Bioscience, 560485, 561665) for
detection of IL-10, IL-17A, TNF, IFN-gamma, IL-2, IL-4
and IL-6. Briefly, splenocytes were harvested from immunized
mice and transferred in triplicate to non-tissue culture, v-bottom 96 well plates for stimulation with ConA (2 mg/mL),
PBS, SGH (20 mg/mL) and pooled peptides, PP (20 mg/
mL). Cells were incubated at 37 C, 5% CO2 for 24, 48 and
72 hrs. Post incubation, plates were pelleted and supernatant
was collected and stored at ¡80 C until the CBA assay was
performed. Cell supernatants from individual mice within
immunization arms and timepoints were combined for testing. Supernatants were monitored for cytokine production
References
1. Sonenshine D. Biology of Ticks. New York: Oxford
University Press, 1991.
2. Balashov IS. A translation of Bloodsucking ticks (Ixodoidea)–vectors of diseases of man and animals. College
Park, MD: Entomological Society of America, 1972.
3. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science (New York, NY)
1993; 260:1610–6; http://dx.doi.org/10.1126/science.
8503006
4. Mather TN, Mather ME. Intrinsic competence of three
ixodid ticks (Acari) as vectors of the Lyme disease spirochete. J Med Entomol 1990; 27:646-50; PMID:2388239
5. Gern L. Life cycle of Borrelia burgdorferi sensu lato and
transmission to humans. Curr Prob Dermatol 2009;

3058

using an LSRII Flow Cytometer and analyzed using the FloJo
software. Cytokine production is presented as picogram per
mL values above background.
Borrelia challenge of immunized HLA DR3 Mice
Additionally on day 42, the remaining 4 mice from each
immunization arm were challenged with 3 Bb-infected nymphs
as previously stated. Infection status of each animal was determined 3 weeks post challenge, as previously stated to asses any
levels of protection afforded by immunization. qPCR-generated
Bb RecA gene copy number data were analyzed by KruskalWallis ANOVA of Variance on Ranks and the means compared
by Student-Newman-Keul’s test (P < 0.05) (SigmaPlot).

Disclosure of Potential Conflicts of Interest

Two of the contributing authors, Anne S. De Groot and William D. Martin, are senior officers and majority shareholders at
EpiVax, Inc., a privately owned biotechnology company located
in Providence, RI. Leonard Moise is employed by and holds
stock options in EpiVax. These authors acknowledge that there is
a potential conflict of interest related to their relationship with
EpiVax and attest that the work contained in this research report
is free of any bias that might be associated with the commercial
goals of the company.

Acknowledgments

The authors are grateful to Emily Troiano for dissection of
tick salivary glands, Jason LaPorte for assisting with tick infestations and Tori Deschenes for assistance with CBA. We also thank
Dr. Jose Ribeiro for his invaluable informatics assistance with the
tick salivome.

Funding

This work was supported by NIH U19 grant (AI082642) (to
A.D.G.). It is Contribution No. 5404 of the Rhode Island Agriculture Experiment Station. The content is solely the responsibility of the authors and does not necessarily represent the official
views of the National Institute of Allergy and Infectious Diseases
or the National Institutes of Health.

37:18-30; PMID:19367095; http://dx.doi.org/10.
1159/000213068
6. van der Burg SH, Bijker MS, Welters MJP, Offringa R,
Melief CJM. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune
efficacy. Adv Drug Deliv Rev 2006; 58:916-30;
PMID:16979788; http://dx.doi.org/10.1016/j.addr.
2005.11.003
7. Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 1987; 25:557-8;
PMID:3571459
8. Allen JR. Tick resistance: basophils in skin reactions of
resistant guinea pigs. Int J Parasitol 1973; 3:195-200;
PMID:4706571; http://dx.doi.org/10.1016/00207519(73)90024-6

Human Vaccines & Immunotherapeutics

9. Askenase PW, Bagnall BG, Worms MJ. Cutaneous
basophil-associated resistance to ectoparasites (ticks).
I. Transfer with immune serum or immune cells.
Immunology 1982; 45:501-11; PMID:7061108
10. Krause PJ, Grant-Kels JM, Tahan SR, Dardick KR,
Alarcon-Chaidez F, Bouchard K, Visini C, Deriso C,
Foppa IM, Wikel S. Dermatologic changes induced by
repeated Ixodes scapularis bites and implications for
prevention of tick-borne infection. Vector Borne Zoonotic Dis 2009; 9:603-10; PMID:19196014; http://dx.
doi.org/10.1089/vbz.2008.0091
11. Brown SJ, Askenase PW. Immune rejection of ectoparasites (ticks) by T cell and IgG1 antibody recruitment
of basophils and eosinophils. Fed Proc 1983; 42:17449; PMID:6601034
12. Nadif R, Zerimech F, Bouzigon E, Matran R. The role
of eosinophils and basophils in allergic diseases

Volume 10 Issue 10

13.
14.

15.

16.

Downloaded by [72.215.236.254] at 11:14 08 October 2015

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

considering genetic findings. Curr Opin Allergy Clin
Immunol 2013; 13:507-13; PMID:23974679; http://
dx.doi.org/10.1097/ACI.0b013e328364e9c0
Bowman A, Nuttall P, eds. Ticks: Biology, Disease and
Control: Cambridge University Press, 2008; 186-204.
Burke G, Wikel SK, Spielman A, Telford SR, McKay
K, Krause PJ. Hypersensitivity to ticks and Lyme disease risk. Emer Infect Dis 2005; 11:36-41;
PMID:15705320
Nazario S, Das S, de Silva AM, Deponte K, Marcantonio N, Anderson JF, Fish D, Fikrig E, Kantor FS. Prevention of Borrelia burgdorferi transmission in guinea
pigs by tick immunity. Am J Trop Med Hyg 1998;
58:780-5; PMID:9660463
Schoeler GB, Manweiler SA, Wikel SK. Ixodes scapularis: effects of repeated infestations with pathogen-free
nymphs on macrophage and T lymphocyte cytokine
responses of BALB/c and C3H/HeN mice. Exp Parasitol 1999; 92:239-48; PMID:10425152; http://dx.doi.
org/10.1006/expr.1999.4426
Xu Q, Seemanapalli SV, Reif KE, Brown CR, Liang
FT. Increasing the recruitment of neutrophils to the
site of infection dramatically attenuates Borrelia burgdorferi infectivity. J Immunol (Baltimore, Md: 1950)
2007; 178:5109-15; PMID:17404293; http://dx.doi.
org/10.4049/jimmunol.178.8.5109
Gonzalez-Galarza FF CS, Middleton D, Jones AR.
Allele frequency net: a database and online repository
for immune gene frequencies in worldwide populations. Nucleic Acid Res 2011; 39: D913-9;
PMID:21062830; http://dx.doi.org/10.1093/nar/
gkq1128
Kurtenbach K, Hanincova K, Tsao JI, Margos G, Fish
D, Ogden NH. Fundamental processes in the evolutionary ecology of Lyme borreliosis. Nat Rev Micro
2006; 4:660-9; PMID:16894341; http://dx.doi.org/
10.1038/nrmicro1475
De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM,
Gonzalez MA, Martin W, Saint-Aubin C. From
genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001; 19:4385-95; PMID:11483263;
http://dx.doi.org/10.1016/S0264-410X(01)00145-1
Ribeiro JM, Alarcon-Chaidez F, Francischetti IM,
Mans BJ, Mather TN, Valenzuela JG, Wikel SK. An
annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem Mol Biol 2006;
36:111-29;
PMID:16431279;
http://dx.doi.org/
10.1016/j.ibmb.2005.11.005
Francischetti IM, Mather TN, Ribeiro JM. Cloning of
a salivary gland metalloprotease and characterization of
gelatinase and fibrin(ogen)lytic activities in the saliva of
the Lyme disease tick vector Ixodes scapularis. Biochem
Biophys
Res
Commun
2003;
305:869-75;
PMID:12767911; http://dx.doi.org/10.1016/S0006291X(03)00857-X
Maritz-Olivier C, Stutzer C, Jongejan F, Neitz AWH,
Gaspar ARM. Tick anti-hemostatics: targets for future
vaccines and therapeutics. Trends Parasitol 2007;
23:397-407; PMID:17656153; http://dx.doi.org/
10.1016/j.pt.2007.07.005
Moise L, Terry F, Ardito M, Tassone R, Latimer H,
Boyle C, Martin WD, De Groot AS. Universal H1N1
influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and
2011. Hum Vaccines Immunother 2013; 9:1598-607;
PMID:23846304; http://dx.doi.org/10.4161/hv.25598
Moise L, Tassone R, Latimer H, Terry F, Levitz L,
Haran JP, Ross TM, Boyle CM, Martin WD, De
Groot AS. Immunization with cross-conserved H1N1
influenza CD4C T-cell epitopes lowers viral burden in
HLA DR3 transgenic mice. Hum Vaccines Immunother 2013; 9:2060-8; PMID:24045788; http://dx.doi.
org/10.4161/hv.26511
De Groot AS, Martin W. Reducing risk, improving
outcomes: bioengineering less immunogenic protein
therapeutics. Clin Immunol (Orlando, Fla) 2009;

www.landesbioscience.com

27.
28.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

40.

41.

131:189-201; PMID:19269256; http://dx.doi.org/
10.1016/j.clim.2009.01.009
Trager W. Acquired immunity to ticks. J Parasitol
1939; 25:57-81; http://dx.doi.org/10.2307/3272160
Wikel SK. Host immunity to ticks. Annu Rev Entomol
1996; 41:1-22; PMID:8546443; http://dx.doi.org/
10.1146/annurev.en.41.010196.000245
Heinze DM, Wikel SK, Thangamani S, Alarcon-Chaidez FJ. Transcriptional profiling of the murine cutaneous response during initial and subsequent infestations
with Ixodes scapularis nymphs. Parasit Vectors 2012;
5:26; PMID:22309607; http://dx.doi.org/10.1186/
1756-3305-5-26
Mejri N, Franscini N, Rutti B, Brossard M. Th2 polarization of the immune response of BALB/c mice to Ixodes ricinus instars, importance of several antigens in
activation of specific Th2 subpopulations. Parasite
Immunol 2001; 23:61-9; PMID:11240897; http://dx.
doi.org/10.1046/j.1365-3024.2001.00356.x
Ferreira BR, Silva JS. Successive tick infestations selectively promote a T-helper 2 cytokine profile in mice.
Immunology 1999; 96:434-9; PMID:10233725;
http://dx.doi.org/10.1046/j.1365-2567.1999.00683.x
Schoeler GB, Manweiler SA, Wikel SK. Cytokine
responses of C3H/HeN mice infested with Ixodes scapularis or Ixodes pacificus nymphs. Parasite Immunol
2000; 22:31-40; PMID:10607289; http://dx.doi.org/
10.1046/j.1365-3024.2000.00272.x
Borsky I, Hermanek Jı, Uhlır J, Dusbabek Fe. Humoral
and cellular immune response of BALB/c mice to
repeated infestations with Ixodes ricinus nymphs. Int J
Parasitol 1994; 24:127-32; PMID:8021100; http://dx.
doi.org/10.1016/0020-7519(94)90066-3
Mbow ML, Christe M, Rutti B, Brossard M. Absence
of acquired resistance to nymphal Ixodes ricinus ticks
in BALB/c mice developing cutaneous reactions. J Parasitol 1994; 80:81-7; PMID:8308662; http://dx.doi.
org/10.2307/3283349
Christe M, Rutti B, Brossard M. Influence of the genetic
background and parasite load of mice on the immune
response developed against nymphs of Ixodes ricinus. Parasitol Res 1999; 85:557-61; PMID:10382605; http://dx.
doi.org/10.1007/s004360050595
Narasimhan S, Deponte K, Marcantonio N, Liang X,
Royce TE, Nelson KF, Booth CJ, Koski B, Anderson
JF, Kantor F, et al. Immunity against Ixodes scapularis
salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission. PloS One 2007; 2:e451; PMID:17505544;
http://dx.doi.org/10.1371/journal.pone.0000451
Bechara GH, Szabo MP, Mukai LS, Rosa PC. Immunisation of dogs, hamsters and guinea pigs against Rhipicephalus sanguineus using crude unfed adult tick extracts.
Vet Parasitol 1994; 52:79-90; PMID:8030191; http://dx.
doi.org/10.1016/0304-4017(94)90038-8
Titus RG, Bishop JV, Mejia JS. The immunomodulatory factors of arthropod saliva and the potential for
these factors to serve as vaccine targets to prevent pathogen transmission. Parasite Immunol 2006; 28:131-41;
PMID:16542315
Ferreira BR, Silva JS. Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFNg-induced macrophage microbicidal activity. Vet
Immunol
Immunopathol
1998;
64:279-93;
PMID:9730222;
http://dx.doi.org/10.1016/S01652427(98)00135-4
Moise L, Gutierrez AH, Bailey-Kellogg C, Terry F,
Leng Q, Abdel Hady KM, Verberkmoes NC, Sztein
MB, Losikoff PT, Martin WD, et al. The two-faced T
cell epitope: examining the host-microbe interface with
JanusMatrix. Hum Vaccines Immunother 2013;
9:1577-86;
PMID:23584251;
http://dx.doi.org/
10.4161/hv.24615
Moise L, Buller RM, Schriewer J, Lee J, Frey SE, Weiner DB, Martin W, De Groot AS. VennVax, a DNAprime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia

Human Vaccines & Immunotherapeutics

42.

43.

44.

45.

46.

47.

48.

49.

50.

51.

52.

53.

infection by T cell response alone. Vaccine 2011;
29:501-11;
PMID:21055490;
http://dx.doi.org/
10.1016/j.vaccine.2010.10.064
Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J,
Rogers AB, Martin W, De Groot AS. HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination
in a mouse model. Vaccine 2011; 29:2085-91;
PMID:21236233; http://dx.doi.org/10.1016/j.vaccine.
2010.12.130
Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci
O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP,
Sinigaglia F, et al. Generation of tissue-specific and
promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999; 17:555-61; PMID:10385319; http://dx.doi.
org/10.1038/9858
Bond KB, Sriwanthana B, Hodge TW, De Groot AS,
Mastro TD, Young NL, Promadej N, Altman JD, Limpakarnjanarat K, McNicholl JM. An HLA-directed
molecular and bioinformatics approach identifies new
HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte
epitopes in HIV-1-infected Thais. AIDS Res Hum Retrov 2001; 17:703-17; PMID:11429111; http://dx.doi.
org/10.1089/088922201750236988
Dong Y, Demaria S, Sun X, Santori FR, Jesdale BM,
De Groot AS, Rom WN, Bushkin Y. HLA-A2restricted CD8C-cytotoxic-T-cell responses to novel
epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase.
Infect
Immun
2004;
72:2412-5;
PMID:15039371; http://dx.doi.org/10.1128/IAI.72.
4.2412-2415.2004
Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW,
Nepom GT, Baxter-Lowe LA. Antibiotic-refractory
Lyme arthritis is associated with HLA-DR molecules
that bind a Borrelia burgdorferi peptide. J Exp Med
2006; 203:961-71; PMID:16585267; http://dx.doi.
org/10.1084/jem.20052471
Southwood S, Sidney J, Kondo A, del Guercio MF,
Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey
HM, Sette A. Several common HLA-DR types share
largely overlapping peptide binding repertoires. J
Immunol (Baltimore, Md: 1950) 1998; 160:3363-73;
PMID:9531296
Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J,
Strauss G, H€ammerling GJ, David CS. HLA-DRB1
polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med
1996; 184:1167-72; PMID:9064334; http://dx.doi.
org/10.1084/jem.184.3.1167
Strauss G, Vignali DA, Schonrich G, Hammerling GJ.
Negative and positive selection by HLA-DR3(DRw17)
molecules in transgenic mice. Immunogenetics 1994;
40:104-8; PMID:8026858
Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur
M, Benoist C, Mathis D. Mice lacking MHC class II
molecules. Cell 1991; 66:1051-66; PMID:1909605;
http://dx.doi.org/10.1016/0092-8674(91)90448-8
Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced
arthritis: a novel model for human polyarthritis. J Exp
Med 1996; 183:27-37; PMID:8551230; http://dx.doi.
org/10.1084/jem.183.1.27
Yang L, Weis JH, Eichwald E, Kolbert CP, Persing
DH, Weis JJ. Heritable susceptibility to severe Borrelia
burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in
tissues.
Infect
Immun
1994;
62:492-500;
PMID:8300208
Morrison TB, Ma Y, Weis JH, Weis JJ. Rapid and sensitive quantification of borrelia burgdorferi-infected
mouse tissues by continuous fluorescent monitoring of
PCR. J Clin Microbiol 1999; 37:987-92;
PMID:10074514

3059

